TSE:2160Biotechs
GNI Group (TSE:2160) Valuation After Tax Expense Revision And Narrowed FY2025 Losses
GNI Group (TSE:2160) has revised its FY2025 consolidated results after correcting overstated tax expenses tied to subsidiary activities, modestly narrowing reported operating and net losses and giving investors a clearer view of its tax burden.
See our latest analysis for GNI Group.
The revision to tax expenses lands at a time when sentiment around GNI Group has already been improving, with a 44.64% 30 day share price return, a 56.77% year to date share price return, and a very large 3 year...